Read the full-text of this article for free

Title: The road to commercialisation: expanding digital therapeutics across international markets

Authors: Amy Lee; Grigorij Ljubownikow

Addresses: Management and International Business, The University of Auckland, Owen G Glenn Building, 12 Grafton Road, Auckland 1142, New Zealand ' Management and International Business, The University of Auckland, Level 3, Owen G Glenn Building, 12 Grafton Road, Auckland 1142, New Zealand

Abstract: In recent years, numerous digital therapeutics firms have rapidly commercialised and expanded internationally, yet, the intersection between these processes needs to be better understood. Existing literature treats commercialisation and internationalisation as largely separate processes, with theories like 'international new ventures' explaining rapid internationalisation but providing limited insights into born-digital therapeutics firms' commercialisation strategies. This study explores the overlap between commercialisation and internationalisation, focusing on the digital therapeutics industry. Three aggregate dimensions - new product development, strategic market entry, and commercialisation environment - are identified through semi-structured interviews. These dimensions reveal that born-digital therapeutics firms simultaneously pursue both commercialisation and internationalisation. The study advocates for integrating internationalisation elements into commercialisation frameworks, contributing to the understanding of bringing digital therapeutics products to market and entrepreneurial internationalisation literature.

Keywords: commercialisation; internationalisation; digital therapeutics; born-digital; process.

DOI: 10.1504/IJTTC.2024.143991

International Journal of Technology Transfer and Commercialisation, 2024 Vol.21 No.5, pp.1 - 25

Received: 30 May 2024
Accepted: 14 Oct 2024
Published online: 17 Jan 2025 *